RxDoctor Payments Data

Shannon Wesley

Colon & Rectal Surgery · Lima, OHNPI 1225320526

Payments from drug & device makers

What this record shows

The money is spread across several categories — gifts (50.2%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Braintree Laboratories, Inc. at 50.2% of the total. That places this record below the midpoint for colon & rectal surgery clinicians in OH, where the typical reported total is $1,025.

$822in general payments, 2019–2025

Across 26 payments — averaging $31.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Braintree Laboratories, Inc.$413
  • Aimmune Therapeutics, Inc.$82
  • Johnson & Johnson$76
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$48
  • Atricure, Inc.$44
  • Ferring Pharmaceuticals Inc.$33
  • plus $126 from 7 others

What the payments were for

  • Consulting fees$182%
  • Food & beverage$39148%
  • Gifts$41350%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$822 in reported general payments places this provider in the 40th percentile of 101 colon & rectal surgery providers in Ohio.

See all colon & rectal surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$33,049
Medicare patients
113
Services billed
290

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide18$13,216
SutabSod Sulf/Pot Chloride/Mag Sulf29$4,676
Colestipol Hcl26$2,691
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine30$1,039
Hydrocortisone40$614
Dicyclomine Hcl17$292
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen11$75

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$27$13,21618 claims
Braintree Laboratories, Inc.Sutab$413$4,67629 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 101 colon & rectal surgery providers in Ohio.

Other colon & rectal surgery in Lima

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →